- Home
- AXSM vs CYTK Comparison
AXSM vs CYTK Comparison
Compare AXSM & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- CYTK
- Stock Information
- Founded
- AXSM 2012
- CYTK 1997
- Country
- AXSM United States
- CYTK United States
- Employees
- AXSM N/A
- CYTK N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- CYTK Biotechnology: Pharmaceutical Preparations
- Sector
- AXSM Health Care
- CYTK Health Care
- Exchange
- AXSM Nasdaq
- CYTK Nasdaq
- Market Cap
- AXSM 5.1B
- CYTK 5.6B
- IPO Year
- AXSM 2015
- CYTK 2004
- Fundamental
- Price
- AXSM $107.76
- CYTK $31.70
- Analyst Decision
- AXSM Strong Buy
- CYTK Buy
- Analyst Count
- AXSM 15
- CYTK 19
- Target Price
- AXSM $170.20
- CYTK $77.33
- AVG Volume (30 Days)
- AXSM 655.3K
- CYTK 2.3M
- Earning Date
- AXSM 05-05-2025
- CYTK 05-06-2025
- Dividend Yield
- AXSM N/A
- CYTK N/A
- EPS Growth
- AXSM N/A
- CYTK N/A
- EPS
- AXSM N/A
- CYTK N/A
- Revenue
- AXSM $432,157,000.00
- CYTK $19,218,000.00
- Revenue This Year
- AXSM $63.52
- CYTK $55.84
- Revenue Next Year
- AXSM $63.32
- CYTK $646.96
- P/E Ratio
- AXSM N/A
- CYTK N/A
- Revenue Growth
- AXSM 72.16
- CYTK 412.21
- 52 Week Low
- AXSM $64.11
- CYTK $31.67
- 52 Week High
- AXSM $139.13
- CYTK $68.44
- Technical
- Relative Strength Index (RSI)
- AXSM 46.37
- CYTK 29.83
- Support Level
- AXSM $103.15
- CYTK $31.67
- Resistance Level
- AXSM $120.00
- CYTK $43.51
- Average True Range (ATR)
- AXSM 3.51
- CYTK 1.97
- MACD
- AXSM 0.66
- CYTK -0.78
- Stochastic Oscillator
- AXSM 29.45
- CYTK 0.21
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.